Medicare ACO中癌症患者临终激进治疗比较
该横断面观察研究比较了2013—2014年死亡的66岁及以上Medicare按服务收费(FFS)癌症受益人中,归属于ACO者与倾向评分匹配的非ACO者临终激进照护指标。结果显示ACO归属者临终最后1个月ICU入住率更高(37.7% vs 34.0%;校正差值+2.8个百分点,95%CI 1.0~4.6),重复住院更少(14.5% vs 15.2%;
要点
- ACO归属癌症患者临终最后1个月ICU入住率高于非ACO者。
- ACO归属者临终最后1个月重复住院率低于非ACO者。
- 化疗时机、急诊就诊及临终关怀入组等其余激进照护指标两组无差异。
核心结论
- 与未归属ACO者相比,归属ACO的癌症患者临终最后1个月重复住院更少但ICU入住更多,其他激进照护指标相似。
研究设计与样本
- 横断面观察研究,比较ACO归属受益人与倾向评分匹配的非ACO受益人。
- 研究对象为2013—2014年死亡、66岁及以上、有癌症诊断的Medicare FFS受益人。
- 覆盖美国21个医院转诊区(HRR)。
主要发现
- ACO归属者临终最后1个月ICU入住率为37.7%,非ACO者为34.0%;校正差值+2.8个百分点(95%CI 1.0~4.6)。
- 随着ACO渗透率升高,ICU入住率呈下降趋势(P<.01)。
- 在中和高ACO渗透率HRR中,ACO患者ICU入住率均高于非ACO患者。
- 其他激进临终照护指标两组间无差异。
关键数值与推荐
- 激进临终照护指标包括:临终最后1个月≥1次ICU入住、≥1个月≥2次住院、临终最后1个月≥2次急诊就诊、死亡前2周内化疗、未入临终关怀或死亡前3天内入临终关怀。
- 分析校正了受益人人口学与临床特征及执业特征。
临床怎么用
- 提示ACO在改善癌症患者临终照护方面仍有空间,尤其需关注临终最后1个月ICU入住问题。
- 评价ACO临终照护质量时应同时看ICU入住与重复住院等多项指标。
局限性
- 原文摘要未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare aggressiveness of end-of-life (EoL) care for older cancer patients attributed to Medicare Shared Savings Programs with that for similar fee for service (FFS) beneficiaries not in an accountable care organization (ACO) and examine whether observed differences in EoL care utilization vary across markets that differ in ACO penetration. DESIGN: Cross-sectional observational study comparing ACO-attributed beneficiaries with propensity score-matched beneficiaries not attributed to an ACO. SETTING: A total of 21 hospital referral regions (HRRs) in the United States. PARTICIPANTS: Medicare FFS beneficiaries with a cancer diagnosis who were 66 years or older and died in 2013-2014. MEASUREMENTS: Outcome measures were claims-based quality measures of aggressive EoL care: (1) one or more intensive care unit (ICU) admissions in the last month of life, (2) two or more hospitalizations in the last month of life, (3) two or more emergency department visits in the last month of life, (4) chemotherapy 2 weeks or less before death, and (5) no hospice enrollment or hospice enrollment within 3 days of death. Analyses were adjusted for demographic and clinical characteristics of beneficiaries and practice characteristics. RESULTS: Compared with beneficiaries not in an ACO, ACO-attributed beneficiaries had a higher rate of ICU admission during the last month of life (37.7% vs 34.0%; adjusted difference = +2.8 percentage points; 95% confidence interval (CI) = 1.0-4.6) but fewer repeated hospitalizations (14.5% vs 15.2%; adjusted difference = -1.7 percentage points; CI = -3.1 to -.3). Other measures did not differ for the two groups. Although the ICU admission rates tended to decrease as ACO-penetration rates increased (P < .01), ACO patients had higher rates of ICU admission than non-ACO patients in both medium and high ACO-penetration HRRs. CONCLUSION: Cancer patients attributed to ACOs had fewer repeated hospitalizations but more ICU admissions in the last month of life than non-ACO patients; they had similar rates of other measures of aggressive care at the EoL. This suggests opportunities for ACOs to improve EoL care for cancer patients. J Am Geriatr Soc 67:961-968, 2019.
引用
- Kim H, Keating NL, Perloff JN, et al. Aggressive Care near the End of Life for Cancer Patients in Medicare Accountable Care Organizations. J Am Geriatr Soc. 2019. PMID: 30969439. doi:10.1111/jgs.15914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。